The relationship between fertility, reproductive hormones, and risk of malignant melanoma has acquired much interest in recent years. Melanocytes are hormonally responsive cells, and some in vitro studies demonstrated that estrogen hormones stimulate the growth of melanocytes. Moreover, estrogen receptors have been identified in melanoma cells, as well as in melanocytic nevi and in normal skin. Some evidences suggest a possible link between fertility treatments and the increased risk of malignant melanoma. This article addresses this association through a scrupulous search of the literature published thus far. The aim of this review is to determine the incidence of malignant melanoma in women treated with fertility drugs and to examine if the exposure to fertility treatments really increases the risk of malignant melanoma. In particular, our analysis focused on the different types of drugs and different treatment schedules used. Finally, this study provides additional insights regarding the long-term relationships between fertility drugs and the risk of malignant melanoma. © 2014 International Society of Oncology and BioMarkers (ISOBM).

Correlation between fertility drugs use and malignant melanoma incidence: the state of the art / Tomao, Federica; Papa, Anselmo; LO RUSSO, Giuseppe; Sara, Zuber; Spinelli, GIAN PAOLO; Luigi, Rossi; Caruso, Davide; Prinzi, Natalie; Stati, Valeria; BENEDETTI PANICI, Pierluigi; Tomao, Silverio. - In: TUMOR BIOLOGY. - ISSN 1010-4283. - STAMPA. - 35:9(2014), pp. 8415-8424. [10.1007/s13277-014-2230-4]

Correlation between fertility drugs use and malignant melanoma incidence: the state of the art

TOMAO, FEDERICA;PAPA, ANSELMO;LO RUSSO, GIUSEPPE;SPINELLI, GIAN PAOLO;CARUSO, DAVIDE;PRINZI, NATALIE;STATI, VALERIA;BENEDETTI PANICI, PIERLUIGI;TOMAO, SILVERIO
2014

Abstract

The relationship between fertility, reproductive hormones, and risk of malignant melanoma has acquired much interest in recent years. Melanocytes are hormonally responsive cells, and some in vitro studies demonstrated that estrogen hormones stimulate the growth of melanocytes. Moreover, estrogen receptors have been identified in melanoma cells, as well as in melanocytic nevi and in normal skin. Some evidences suggest a possible link between fertility treatments and the increased risk of malignant melanoma. This article addresses this association through a scrupulous search of the literature published thus far. The aim of this review is to determine the incidence of malignant melanoma in women treated with fertility drugs and to examine if the exposure to fertility treatments really increases the risk of malignant melanoma. In particular, our analysis focused on the different types of drugs and different treatment schedules used. Finally, this study provides additional insights regarding the long-term relationships between fertility drugs and the risk of malignant melanoma. © 2014 International Society of Oncology and BioMarkers (ISOBM).
2014
ovarian stimulation; infertility; in vitro fertilization; invasive melanoma; fertility drugs
01 Pubblicazione su rivista::01a Articolo in rivista
Correlation between fertility drugs use and malignant melanoma incidence: the state of the art / Tomao, Federica; Papa, Anselmo; LO RUSSO, Giuseppe; Sara, Zuber; Spinelli, GIAN PAOLO; Luigi, Rossi; Caruso, Davide; Prinzi, Natalie; Stati, Valeria; BENEDETTI PANICI, Pierluigi; Tomao, Silverio. - In: TUMOR BIOLOGY. - ISSN 1010-4283. - STAMPA. - 35:9(2014), pp. 8415-8424. [10.1007/s13277-014-2230-4]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/646600
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact